NUTX Relative Valuation
NUTX's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, NUTX is overvalued; if below, it's undervalued.
Historical Valuation
Nutex Health Inc (NUTX) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of -24.06. The fair price of Nutex Health Inc (NUTX) is between NaN to NaN according to relative valuation methord.
Relative Value
Fair Zone
NaN-NaN
Current Price：152.53
Fair
8.96
PE
1Y
3Y
5Y
Trailing
Forward
3.63
EV/EBITDA
Nutex Health Inc. (NUTX) has a current EV/EBITDA of 3.63. The 5-year average EV/EBITDA is 61.40. The thresholds are as follows: Strongly Undervalued below -157.90, Undervalued between -157.90 and -48.25, Fairly Valued between 171.05 and -48.25, Overvalued between 171.05 and 280.70, and Strongly Overvalued above 280.70. The current Forward EV/EBITDA of 3.63 falls within the Historic Trend Line -Fairly Valued range.
3.05
EV/EBIT
Nutex Health Inc. (NUTX) has a current EV/EBIT of 3.05. The 5-year average EV/EBIT is 111.66. The thresholds are as follows: Strongly Undervalued below -1111.65, Undervalued between -1111.65 and -499.99, Fairly Valued between 723.32 and -499.99, Overvalued between 723.32 and 1334.98, and Strongly Overvalued above 1334.98. The current Forward EV/EBIT of 3.05 falls within the Historic Trend Line -Fairly Valued range.
0.91
PS
Nutex Health Inc. (NUTX) has a current PS of 0.91. The 5-year average PS is 3.10. The thresholds are as follows: Strongly Undervalued below -11.42, Undervalued between -11.42 and -4.16, Fairly Valued between 10.37 and -4.16, Overvalued between 10.37 and 17.63, and Strongly Overvalued above 17.63. The current Forward PS of 0.91 falls within the Historic Trend Line -Fairly Valued range.
0.00
P/OCF
Nutex Health Inc. (NUTX) has a current P/OCF of 0.00. The 5-year average P/OCF is 1.53. The thresholds are as follows: Strongly Undervalued below -5.09, Undervalued between -5.09 and -1.78, Fairly Valued between 4.83 and -1.78, Overvalued between 4.83 and 8.14, and Strongly Overvalued above 8.14. The current Forward P/OCF of 0.00 falls within the Historic Trend Line -Fairly Valued range.
0.00
P/FCF
Nutex Health Inc. (NUTX) has a current P/FCF of 0.00. The 5-year average P/FCF is -90.81. The thresholds are as follows: Strongly Undervalued below -670.78, Undervalued between -670.78 and -380.80, Fairly Valued between 199.17 and -380.80, Overvalued between 199.17 and 489.16, and Strongly Overvalued above 489.16. The current Forward P/FCF of 0.00 falls within the Historic Trend Line -Fairly Valued range.
Nutex Health Inc (NUTX) has a current Price-to-Book (P/B) ratio of 2.87. Compared to its 3-year average P/B ratio of 3.21 , the current P/B ratio is approximately -10.54% higher. Relative to its 5-year average P/B ratio of 5.84, the current P/B ratio is about -50.87% higher. Nutex Health Inc (NUTX) has a Forward Free Cash Flow (FCF) yield of approximately 0.00%. Compared to its 3-year average FCF yield of 6.08%, the current FCF yield is approximately -100.00% lower. Relative to its 5-year average FCF yield of 6.02% , the current FCF yield is about -100.00% lower.
3.41
P/B
Median3y
3.21
Median5y
5.84
18.71
FCF Yield
Median3y
6.08
Median5y
6.02
Competitors Valuation Multiple
The average P/S ratio for NUTX's competitors is , providing a benchmark for relative valuation. Nutex Health Inc Corp (NUTX) exhibits a P/S ratio of , which is NaN% above the industry average. Given its robust revenue growth of 239.87%, this premium appears sustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
Revenue Growth
Market Cap
Performance Decomposition
1Y
3Y
5Y
Market capitalization of NUTX increased by 394.76% over the past 1 year. The primary factor behind the change was an increase in P/E Change from 1.16 to 8.72.
The secondary factor is the Revenue Growth, contributed 239.87%to the performance.
Overall, the performance of NUTX in the past 1 year is driven by P/E Change. Which is more unsustainable.
People Also Watch
FAQ
Is Nutex Health Inc (NUTX) currently overvalued or undervalued?
What is Nutex Health Inc (NUTX) fair value?
How does NUTX's valuation metrics compare to the industry average?
What is the current P/B ratio for Nutex Health Inc (NUTX) as of Dec 05 2025?
What is the current FCF Yield for Nutex Health Inc (NUTX) as of Dec 05 2025?
What is the current Forward P/E ratio for Nutex Health Inc (NUTX) as of Dec 05 2025?